Novo Nordisk Operating Income 2010-2024 | NVO

Novo Nordisk operating income for the twelve months ending September 30, 2024 was $17.235B, a 28.93% increase year-over-year.

  • Novo Nordisk annual operating income for 2023 was $14.894B, a 40.6% increase from 2022.
  • Novo Nordisk annual operating income for 2022 was $10.593B, a 13.53% increase from 2021.
  • Novo Nordisk annual operating income for 2021 was $9.33B, a 12.52% increase from 2020.

Novo Nordisk Operating Income 2010-2024 | NVO

  • Novo Nordisk annual operating income for 2023 was $14.894B, a 40.6% increase from 2022.
  • Novo Nordisk annual operating income for 2022 was $10.593B, a 13.53% increase from 2021.
  • Novo Nordisk annual operating income for 2021 was $9.33B, a 12.52% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B